Nuclear Medicine Innovation1

[WP-28-3] Synthesis and evaluation of At-211 labeled TRT-radiopharmaceuticals (At-AITM) for melanoma with overexpressed metabotropic glutamate receptor 1

Masayuki Hanyu¹、Lin Xie¹、Yiding Zhang¹、Katsuyuki Minegishi¹、Ayumi Kadoma¹、Kuan Hu¹、Masayuki Fujinaga¹、Kotaro Nagatsu¹、Noriko Ishioka²、M.R Zhang¹ (1.Department of Advanced Nuclear Medicine science, Quantum Life and Medicine Science Directorate, National Institute for Quantum Science and Technology、2.Department of Radiation-Applied Biology Research, National Institute for Quantum Science and Technology)